Cerus Corp (CERS) 7.31 $CERS Cerus (CERS) in Focus:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cerus Corp (CERS) 7.31 $CERS

Cerus (CERS) in Focus: Stock Moves 6% Higher in Session
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 7:05AM CDT
Cerus Corporation (CERS) was a big mover last session, as the company saw its shares rise a little over 6% on the day.
CERS: 7.31 (-0.08), LMAT: 17.89 (+0.69)

Look for Shares of Cerus to Potentially Rebound after Yesterday's 2.46% Sell Off
Comtex SmarTrend(R) - Wed Jul 13, 4:04PM CDT
Cerus (NASDAQ:CERS) traded in a range yesterday that spanned from a low of $6.28 to a high of $6.56. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $6.39 on volume of 371,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CERS: 7.31 (-0.08)

Cerus Provides an Update on Adoption by Blood Centers of America Members for the INTERCEPT Blood System for Platelets and Plasma
BusinessWire - Mon Jul 11, 7:30AM CDT
Cerus Corporation (NASDAQ:CERS) announced today that blood center members representing 54% of the aggregate volume of platelets produced by Blood Centers of America (BCA) have executed participation agreements for adoption of the INTERCEPT Blood System.
CERS: 7.31 (-0.08)

CORRECTING and REPLACING Cerus to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference on July 13, 2016
BusinessWire - Fri Jul 08, 12:39PM CDT
In the first paragraph, presentation time should read 1:00 PM ET (instead of 1:30 PM ET).
CERS: 7.31 (-0.08)

Noteworthy Friday Option Activity: CERS, PODD, JUNO
DividendChannel.com - Fri Jul 08, 10:31AM CDT
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Cerus Corp. , where a total volume of 6,653 contracts has been traded thus far today, a contract volume which is representative of...
CERS: 7.31 (-0.08)

Cerus and CEI Announce Donation of INTERCEPT Blood System Kits to HEMORIO for Emergency Preparedness Ahead of the Summer Olympic Games in Rio de Janeiro
BusinessWire - Wed Jul 06, 7:30AM CDT
Cerus Corporation (NASDAQ:CERS) and its distribution partner CEI Group (Brazil) today announced a donation of INTERCEPT Blood System pathogen reduction kits for platelets and plasma to HEMORIO, a public hospital responsible for transfusion medicine and hematology care for the state of Rio de Janeiro and part of the State Health Department and coordinator of the State Blood Network. HEMORIO is also the designated emergency preparedness blood center in Rio de Janeiro for the Summer Olympic Games, and this donation is aimed at protecting HEMORIO's platelet and plasma transfusion needs for emergency preparedness during the Olympic Games.
CERS: 7.31 (-0.08)

Cerus Announces Agreement with BARDA for Potential Funding of up to Approximately $180 Million to Advance Its INTERCEPT Red Blood Cell Program
BusinessWire - Sun Jun 19, 3:00PM CDT
Cerus Corporation (NASDAQ: CERS), a biomedical products company focused on improving blood transfusion safety, today announced an agreement with the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response, to support Cerus' clinical development program for pathogen reduction of red blood cell (RBC) components, including access to funding that could support various activities, including funding studies necessary to support an FDA submission and accelerate commercial scale up to facilitate potential adoption by U.S. blood centers.
CERS: 7.31 (-0.08)

Showpad Helps Cerus Corporation Share Vital Information During Zika Epidemic
PR Newswire Europe - Wed Jun 01, 1:30AM CDT
Showpad, the leading sales enablement platform that guides reps to results, today announced that its customer Cerus Corporation, a biomedical company focused in the field of blood transfusion safety, is using Showpad to help educate its blood center customers about ways to maintain the safety of the blood supply during a Zika epidemic. Cerus is able to leverage the Showpad platform quickly and efficiently to share vital medical information with its field sales organization.
CERS: 7.31 (-0.08)

How Well are These Healthcare Stocks Performing? - Radius Health, Cerus, Arrowhead Pharma, and Five Prime Therapeutics
PR Newswire - Thu May 26, 7:50AM CDT
Despite the volatility that continues to envelop the Biotech industry, investors see value in this space. Today's pre-market research on ActiveWallSt.com directs the investor community's focus on the following Healthcare equities: Radius Health Inc. (NASDAQ: RDUS), Cerus Corp. (NASDAQ: CERS), Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR), and Five Prime Therapeutics Inc. (NASDAQ: FPRX). Register with us today for these stock technical briefings at:
CERS: 7.31 (-0.08), RDUS: 47.01 (-0.11), ARWR: 5.86 (-0.10), FPRX: 51.57 (+0.88)

Health Canada Approves INTERCEPT Blood System for Plasma
BusinessWire - Mon May 23, 7:30AM CDT
Cerus Corporation (NASDAQ:CERS) today announced that Health Canada has approved the INTERCEPT Blood System for plasma. The INTERCEPT Blood System for plasma is intended to be used for the ex vivo preparation of pathogen-reduced, whole blood derived or apheresis plasma in order to reduce the risk of transfusion-transmitted infection (TTI).
CERS: 7.31 (-0.08)

Cerus reports 1Q loss
Automated Insights - Tue May 03, 3:37PM CDT
CONCORD, Calif. (AP) _ Cerus Corp. (CERS) on Tuesday reported a loss of $16.9 million in its first quarter.
CERS: 7.31 (-0.08)

Cerus Corporation Reports First Quarter 2016 Results
BusinessWire - Tue May 03, 3:01PM CDT
Cerus Corporation (NASDAQ:CERS) today announced financial results for the first quarter ended March 31, 2016.
CERS: 7.31 (-0.08)

Cerus Announces that the Walter Reed National Military Medical Center Has Entered Into Routine Use of the INTERCEPT Blood System
BusinessWire - Tue May 03, 7:30AM CDT
Cerus Corporation (NASDAQ:CERS), a biomedical products company focused in the field of blood transfusion safety, announced today that the Walter Reed National Military Medical Center (Walter Reed), a component of the Armed Services Blood Program, has begun routine use of the INTERCEPT Blood System for apheresis platelets. Walter Reed transfuses approximately 1,000 apheresis platelet units annually.
CERS: 7.31 (-0.08)

Cerus to Release First Quarter 2016 Results on May 3, 2016
BusinessWire - Tue Apr 19, 7:30AM CDT
Cerus Corporation (NASDAQ:CERS) announced today that its first quarter results will be released on Tuesday, May 3, 2016, after the close of the stock market. The company will host a conference call and webcast at 4:15 PM ET that afternoon, during which management will discuss the Company's financial results and provide a general business overview and outlook.
CERS: 7.31 (-0.08)

The Race to Cure the Zika Virus is On, and This Company May Have the Best Solution
Sean Williams, The Motley Fool - Motley Fool - Sat Apr 16, 1:18PM CDT
The Aedes aegypti mosquito has become public enemy No. 1. Image source: Centers for Disease Control and Prevention.  The Zika virus has been around for decades, but its prevalence has exploded since 2014. The virus itself, which is spread by the...
CERS: 7.31 (-0.08), INO: 10.42 (+0.54), MRK: 58.66 (unch), NLNK: 10.49 (-0.09), XON: 27.38 (+2.05), GSK: 45.25 (+0.18), SNY: 42.49 (-0.14)

Cerus Receives FDA Approval for Use of the INTERCEPT Blood System for Platelets Suspended in 100% Plasma
BusinessWire - Wed Mar 16, 7:30AM CDT
Cerus Corporation (NASDAQ: CERS), a biomedical products company focused on improving blood transfusion safety, today announced U.S. Food and Drug Administration (FDA) approval of the INTERCEPT Blood System for treatment of platelets suspended in 100% plasma. This extended label claim further enhances compatibility with commonly used platelet collection methods.
CERS: 7.31 (-0.08)

Cerus Announces the Inclusion of Pathogen Reduction Technology in FDA's Revised Guidance Document on Bacterial Safety Standards for Platelets
BusinessWire - Tue Mar 15, 7:30AM CDT
Cerus Corporation (NASDAQ:CERS) announced today that the U.S. Food and Drug Administration (FDA) has issued a revised draft guidance document titled "Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion; Draft Guidance for Industry." The document is intended to provide blood centers with recommendations for controlling the risk of bacterial contamination of platelets, and pathogen reduction technology is included as a recommended method to reduce the risk of transfusion-transmitted sepsis.
CERS: 7.31 (-0.08)

Covered Call Alerts For Kinder Morgan, Himax Technologies Inc, US Steel, Yahoo! and CERUS Corporation Released By InvestorsObserver
PR Newswire - Thu Mar 10, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for KMI, HIMX, X, YHOO and CERS.
CERS: 7.31 (-0.08), KMI: 19.56 (-0.77), YHOO: 38.80 (+0.61), HIMX: 8.99 (+0.04), X: 26.57 (-0.92)

Blood Centers of America Selects Cerus as its Supply Partner for Pathogen Reduction Technology
BusinessWire - Wed Mar 09, 7:00AM CST
Cerus Corporation (NASDAQ: CERS) and Blood Centers of America (BCA) announced today that they have entered into an agreement with Cerus as a BCA preferred supplier.
CERS: 7.31 (-0.08)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lear Gears Up for Goldman Sachs Event Spotlight

Updated Category News Views 132

Lear Prepares for the Big Stage in London Autumn leaves and industry insights are falling in full swing as Lear Corporation gets its ducks in a row for the upcoming Goldman Sachs 18th Annual Industrials & Autos Week. Kicking off on December 3, 2026, this gathering in London isn't just another checkbox on their corporate calendar—it's a prime moment in the spotlight....

Continue Reading
Ranger and Smith Unveil Tea-Infused Chocolate Bar

Updated Category News Views 88

Fresh Collaborations in Portland's Culinary Scene Ah, the sweet crossover in Portland's food scene is once again in the spotlight with a new entry that's sure to titillate taste buds. Ranger Chocolate Co. and Steven Smith Teamaker are at it again, rolling out a delectable creation that merges the poetic elegance of tea with the indulgent richness of chocolate. Welcome,...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 121

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
Cracking Life Insurance Needs: John Dorsa's Insights

Updated Category News Views 119

Life Insurance: A Necessary Puzzle Life’s uncertainties have a way of putting a wrench in our plans, and nothing screams uncertainty like figuring out life insurance. But fret not! HelloNation’s got insights on this financial maze, and they’ve roped in insurance pro John Dorsa from Ridgeland to help out. Calculating Coverage Needs Forget the one-size-fits-all...

Continue Reading
Veritran's Bold Move: Acquiring PrismaCampaigns Inc.

Updated Category News Views 123

Veritran's Strategic Leap Forward They're not messing around, folks. Veritran just made a power move by acquiring 100% of PrismaCampaigns Inc., and it’s more than just another day in the office. This marks a pivotal expansion of their American footprint, and they're zeroing in on our banks and credit unions with laser precision. Why This Matters for Financial...

Continue Reading
Kansai Powers Up US Grid with Bold Investment Move

Updated Category News Views 135

Betting Big on Battery Storage Let's unpack this big move by Kansai Electric. Anytime a major player like Kansai steps out of its home turf, folks better pay attention. Looks like Kansai's gotten cozy with Elevate and ArcLight, nabbing a minority stake in Prospect Power. This ain't your average widget factory—it's a beefy 150MW/600MWh battery energy storage facility in...

Continue Reading
Exploring Creation: A Fresh Look at Genesis

Updated Category News Views 88

Opening Up Genesis in a New Light Hey, if you’re like most folks, you’ve probably heard Genesis framed as the battleground for science versus religion debates, right? Enter into this mix a fresh take with Robert E. Franzen’s new book, The Narration of Creation. This book asks you to overlook those grand philosophical fights and instead focus on the narrative itself....

Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again

Updated Category News Views 242

Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...

Continue Reading
Intel Hit by Securities Law Suit Amid PC Market Struggles

Updated Category News Views 100

Intel Faces the Music: Legal Battles Unfold So it seems Intel's got itself in a kettle of fish. The tech giant is being dragged into a courtroom dance, courtesy of a class action lawsuit led by DJS Law Group. Shareholders who snapped up Intel shares between July 23 and October 29, 2026, might be scratching their heads, wondering if they bought into a bit of a mirage. A...

Continue Reading
Radnostix Sees Mixed Results, Plans Strategic Shift

Updated Category News Views 90

Radnostix: A Rocky Third Quarter with Glimmers of Hope Alright, sit back and digest this: Radnostix, the company once known as International Isotopes Inc., is currently in the midst of a renovation of sorts. They just reported their financial results for the third quarter of 2026, and honestly, they're a mixed bag. Revenue Falls but Theranostics Shines Quarterly revenue...

Continue Reading

Top 5 Most Recently Viewed Articles

Aardvark Therapeutics Advances Obesity Treatment Research

Updated Category News Views 140

Aardvark Therapeutics Unveils New Data on Obesity Treatments Aardvark Therapeutics, Inc. (AARD) recently showcased significant insights from its metabolic obesity pipeline at the latest conference dedicated to obesity, titled ObesityWeek 2025. This presentation highlighted the promising preclinical results of their innovative drug, ARD-201, which aims to enhance glucose...

Continue Reading
ITC Holdings Corp. Welcomes Carlo Capra as New VP of Engineering

Updated Category News Views 189

ITC Holdings Corp. Names Carlo Capra as Vice President of Engineering ITC Holdings Corp. has recently announced an important leadership change with the appointment of Carlo Capra as the company's new Vice President of Engineering, effective February 26, 2026. This move follows the retirement of Joe Bennett, who has played a vital role in ITC's development during his...

Continue Reading
Safeguarding Your Rights as a WEBTOON Entertainment Shareholder

Updated Category News Views 246

Understanding Your Rights as a WEBTOON Entertainment Shareholder Shareholders are urged to take action promptly, as the time to enforce your rights may be limited. Halper Sadeh LLC, an advocacy law firm focused on shareholder rights, is exploring claims regarding potential breaches of fiduciary duties by some officers and directors of WEBTOON Entertainment Inc. (NASDAQ:...

Continue Reading
TransDigm Group Delivers Strong First Quarter Performance

Updated Category News Views 124

TransDigm Group Reports First Quarter Results for Fiscal 2025 TransDigm Group Incorporated (NYSE: TDG), recognized as a leading designer, producer, and supplier of highly engineered aircraft components, recently announced their financial outcomes for the first quarter of fiscal 2025. First Quarter Financial Highlights In this first quarter, TransDigm Group achieved...

Continue Reading
Understanding Market Movements and TEM Stock Trends

Updated Category News Views 153

Market Activity Around Tempus AI In recent trading sessions, significant bearish sentiment has emerged around Tempus AI (TEM). This shift appears to be fueled by large investors taking notable positions that raise eyebrows among retail traders seeking insights on potential market movements. The Current Trading Landscape Today, we observed unusual activity in the options...

Continue Reading